Marius Pearson
At the October meeting of the MedComms Brunch Club in Oxford, employees of Oxford PharmaGenesis used this year’s Open Access Week as an opportunity to launch the Open Pharma position statement on open access and to present Oxford PharmaGenesis-funded research on open access, clinical trial transparency and the role of professional medical writing support.
Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit Europe in London.
Oxford PharmaGenesis was in Tokyo to see ‘open science’ take centre stage at the 2019 Asia-Pacific Meeting of ISMPP
Lord Lieutenant leads celebrations at global Oxford-based consultancy
A systematic review of the impact of professional medical writing support on the quality, ethics and timeliness of clinical trial reporting has been published in Research Integrity and Peer Review.
Both the Oxford PharmaGenesis US (Brian Falcone and Jake Willet) and UK (Eric Southam and Richard White) offices were represented at The International Publication Planning Meeting (TIPPA) East, in Boston on 24–25 June 2019.
In aid of three Oxfordshire-based charities, three employees of HealthScience communications consultancy Oxford PharmaGenesis scaled the three highest peaks in England, Scotland and Wales within 24 hours comprising the Trifecta 3Peaks Challenge.
Who is publishing their clinical trial results? Do biopharmaceutical industry sponsors carry an unfair burden of the blame for the under-reporting of clinical trial results?
After more than 2 years of hard work, Aston & Cote Summer Fete (held on 22 June) was the perfect event for Aston & Cote Community Trust to celebrate the opening of a new playground for the young children of the village.
Leading medical journals restrict access to industry-funded research, shows a study conducted by researchers at Oxford PharmaGenesis, published in BMJ Open today. This is likely to impede further research and delay patient benefit.
